The role of GPRASP1 mutations in the pathogenesis of arteriovenous malformations
DOI:
https://doi.org/10.61173/d87mky09Keywords:
GPRASP1 gene, arteriovenous malformation, G protein-coupled receptor, Germline mutationsAbstract
Arteriovenous Malformation (AVM) is a sporadic vascular disease caused by the aberrant direct connection between arterioles and veins, resulting in disorganized blood shunting and oxygen level disparities. Previous research has elucidated some of the genetic underpinnings of AVM and related vascular anomalies. Despite its significant prevalence, current therapeutic approaches remain largely conservative, underscoring the need for a deeper understanding of AVM pathogenesis. This study focuses on the GPRASP1 gene, which encodes the G-protein coupled receptor-associated sorting protein 1 (GASP-1), a molecule implicated in vascular development. Utilizing western blotting and cellular assays, we explored the role of GPRASP1 in angiogenesis, neoplastic formation, and other mechanical aspects of AVM. Our findings suggested that mutations in the GPRASP1 gene may contribute to elevated levels of angiogenic factors and altered cellular functions related to angiogenesis, such as enhanced proliferative and migratory capabilities. This research lays the groundwork for identifying novel therapeutic targets in the management of AVM and offers insights into precision medicine approaches.
References
Alluhaibi, R., Alkhayat, L. N., & Aqeeli, W. (2021). Capillary Malformation-Arteriovenous Malformation Syndrome. Cureus, 13(1), e12562. https://doi.org/10.7759/cureus.12562 Amyere, M., Revencu, N., Helaers, R., Pairet, E., Baselga, E., Cordisco, M., Chung, W., Dubois, J., Lacour, J.-P., Martorell, L., Mazereeuw-Hautier, J., Pyeritz, R. E., Amor, D. J., Bisdorff, A., Blei, F., Bombei, H., Dompmartin, A., Brooks, D., Dupont,
J., … Vikkula, M. (2017). Germline Loss-of-Function Mutations in EPHB4 Cause a Second Form of Capillary Malformation- Arteriovenous Malformation (CM-AVM2) Deregulating RAS- MAPK Signaling. Circulation, 136(11), 1037–1048. https://doi. org/10.1161/CIRCULATIONAHA.116.026886
Bameri, O., Salarzaei, M., & Parooie, F. (2021). KRAS/BRAF mutations in brain arteriovenous malformations: A systematic review and meta-analysis. Interventional Neuroradiology, 27(4), 539–546. https://doi.org/10.1177/1591019920982810 Bernabeu, C., Blanco, F., Carmen, L., Garrido Martin, E., &
Botella, L. (2010). Involvement of the TGF-β superfamily signalling pathway in hereditary haemorrhagic telangiectasia. Journal of Applied Biomedicine, 8. https://doi.org/10.2478/ v10136-009-0020-x Brain AVM (arteriovenous malformation)—Symptoms and
causes. (n.d.). Mayo Clinic. Retrieved December 10, 2022, from https://www.mayoclinic.org/diseases-conditions/brain-avm/ symptoms-causes/syc-20350260 Couto, J. A., Huang, A. Y., Konczyk, D. J., Goss, J. A., Fishman,
S. J., Mulliken, J. B., Warman, M. L., & Greene, A. K. (2017). Somatic MAP2K1 Mutations Are Associated with Extracranial Arteriovenous Malformation. The American Journal of Human Genetics, 100(3), 546–554. https://doi.org/10.1016/ j.ajhg.2017.01.018 Eerola, I., Boon, L. M., Mulliken, J. B., Burrows, P. E., Dompmartin, A., Watanabe, S., Vanwijck, R., & Vikkula, M. (2003). Capillary Malformation–Arteriovenous Malformation, a New Clinical and Genetic Disorder Caused by RASA1 Mutations. The American Journal of Human Genetics, 73(6), 1240–1249. https://doi.org/10.1086/379793 Fish, J. E., Flores Suarez, C. P., Boudreau, E., Herman, A. M., Gutierrez, M. C., Gustafson, D., DiStefano, P. V., Cui, M., Chen, Z., De Ruiz, K. B., Schexnayder, T. S., Ward, C. S.,
Radovanovic, I., & Wythe, J. D. (2020). Somatic Gain of KRAS Function in the Endothelium Is Sufficient to Cause Vascular Malformations That Require MEK but Not PI3K Signaling. Circulation Research, 127(6), 727–743. https://doi.org/10.1161/ CIRCRESAHA.119.316500 Gallione, C. J., Repetto, G. M., Legius, E., Rustgi, A. K., Schelley, S. L., Tejpar, S., Mitchell, G., Drouin, E.,
Westermann, C. J. J., & Marchuk, D. A. (2004). A combined syndrome of juvenile polyposis and hereditary hemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Dean&Francis Lancet (London, England), 363(9412), 852–859. https://doi. org/10.1016/S0140-6736(04)15732-2 GPRASP1 G protein-coupled receptor associated sorting protein 1 [Homo sapiens (human)]—Gene—NCBI. (n.d.). Retrieved
December 10, 2022, from https://www.ncbi.nlm.nih.gov/ gene/9737
Greene, A. K., & Orbach, D. B. (2011). Management of Arteriovenous Malformations. Clinics in Plastic Surgery, 38(1), 95–106. https://doi.org/10.1016/j.cps.2010.08.005
Guttmacher, A. E., Marchuk, D. A., & White, R. I. (1995). Hereditary Hemorrhagic Telangiectasia. New England Journal of Medicine, 333(14), 918–924. https://doi.org/10.1056/ NEJM199510053331407 Heimdal, K., Dalhus, B., Rødningen, O. K., Kroken, M., Eiklid, K., Dheyauldeen, S., Røysland, T., Andersen, R., & Kulseth,
M. A. (2016). Mutation analysis in Norwegian families with hereditary hemorrhagic telangiectasia: Founder mutations in ACVRL1. Clinical Genetics, 89(2), 182–186. https://doi. org/10.1111/cge.12612 Hirata, Y., Enoki, R., Kuribayashi-Shigetomi, K., Oda, Y.,
Honma, S., & Honma, K. (2019). Circadian rhythms in Per1, PER2 and Ca2+ of a solitary SCN neuron cultured on a microisland. Scientific Reports, 9, 18271. https://doi. org/10.1038/s41598-019-54654-5 Hong, T., Yan, Y., Li, J., Radovanovic, I., Ma, X., Shao, Y. W., Yu, J., Ma, Y., Zhang, P., Ling, F., Huang, S., Zhang, H., &
Wang, Y. (2019). High prevalence of KRAS/BRAF somatic mutations in brain and spinal cord arteriovenous malformations. Brain: A Journal of Neurology, 142(1), 23–34. https://doi. org/10.1093/brain/awy307
Jakubík, J., & El-Fakahany, E. E. (2010). Allosteric Modulation of Muscarinic Acetylcholine Receptors. Pharmaceuticals, 3(9), 2838–2860. https://doi.org/10.3390/ph3092838 Johnson, D. W., Berg, J. N., Baldwin, M. A., Gallione, C. J., Marondel, I., Yoon, S. J., Stenzel, T. T., Speer, M., Pericak- Vance, M. A., Diamond, A., Guttmacher, A. E., Jackson, C. E., Attisano, L., Kucherlapati, R., Porteous, M. E., & Marchuk, D.
A. (1996). Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nature Genetics, 13(2), 189–195. https://doi.org/10.1038/ng0696-189 Kawasaki, J., Aegerter, S., Fevurly, R. D., Mammoto, A., Mammoto, T., Sahin, M., Mably, J. D., Fishman, S. J., & Chan,
J. (2014). RASA1 functions in EPHB4 signaling pathway to suppress endothelial mTORC1 activity. The Journal of Clinical Investigation, 124(6), 2774–2784. https://doi.org/10.1172/ JCI67084
Laakso, A., & Hernesniemi, J. (2012). Arteriovenous Malformations: Epidemiology and Clinical Presentation. Neurosurgery Clinics, 23(1), 1–6. https://doi.org/10.1016/ j.nec.2011.09.012 Lawton, M. T., Rutledge, W. C., Kim, H., Stapf, C., Whitehead, K. J., Li, D. Y., Krings, T., terBrugge, K., Kondziolka, D.,
Morgan, M. K., Moon, K., & Spetzler, R. F. (2015). Brain arteriovenous malformations. Nature Reviews Disease Primers, 1(1), Article 1. https://doi.org/10.1038/nrdp.2015.8 Lesca, G., Olivieri, C., Burnichon, N., Pagella, F., Carette, M.- F., Gilbert-Dussardier, B., Goizet, C., Roume, J., Rabilloud, M., Saurin, J.-C., Cottin, V., Honnorat, J., Coulet, F., Giraud, S.,
Calender, A., Danesino, C., Buscarini, E., & Plauchu, H. (2007). Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: Data from the French-Italian HHT network. Genetics in Medicine, 9(1), Article 1. https://doi.org/10.1097/ GIM.0b013e31802d8373 Mamai, O., Beleford, D. T., Taylor, M., Basu, S., Cen, X., Trilok, S., Zhang, J., Balmain, A., & Akhurst, R. J. (2022). PTPN14, a modifier of HHT, protects SMAD4 from ubiquitination and turnover to potentiate BMP9 signaling in
endothelial cells (p. 2021.09.29.462397). bioRxiv. https://doi. org/10.1101/2021.09.29.462397 MAPK-ERK 信 号 通 路 —Elabscience. (n.d.). Retrieved
December 10, 2022, from https://www.elabscience.cn/singaling_ pathways-mapkerk_signaling_pathway-239.html McAllister, K. A., Grogg, K. M., Johnson, D. W., Gallione, C. J., Baldwin, M. A., Jackson, C. E., Helmbold, E. A., Markel, D. S., McKinnon, W. C., Murrel, J., McCormick, M. K., Pericak-Vance, M. A., Heutink, P., Oostra, B. A., Haitjema, T., Westerman, C. J. J., Porteous, M. E., Guttmacher, A. E., Letarte, M., & Marchuk,
D. A. (1994). Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nature Genetics, 8(4), Article 4. https://doi.org/10.1038/ ng1294-345 McDonald, J., Wooderchak-Donahue, W., VanSant Webb, C.,
Whitehead, K., Stevenson, D. A., & Bayrak-Toydemir, P. (2015). Hereditary hemorrhagic telangiectasia: Genetics and molecular diagnostics in a new era. Frontiers in Genetics, 6, 1. https://doi. org/10.3389/fgene.2015.00001 Nikolaev, S. I., Vetiska, S., Bonilla, X., Boudreau, E., Jauhiainen, S., Rezai Jahromi, B., Khyzha, N., DiStefano, P. V., Suutarinen, S., Kiehl, T.-R., Mendes Pereira, V., Herman, A. M., Krings, T., Andrade-Barazarte, H., Tung, T., Valiante, T., Zadeh, G., Tymianski, M., Rauramaa, T., … Radovanovic, I. (2018). Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain. New England Journal of Medicine, 378(3), 250–261. https://doi.org/10.1056/NEJMoa1709449 Priemer, D. S., Vortmeyer, A. O., Zhang, S., Chang, H. Y.,
Curless, K. L., & Cheng, L. (2019). Activating KRAS mutations in arteriovenous malformations of the brain: Frequency and clinicopathologic correlation. Human Pathology, 89, 33–39. https://doi.org/10.1016/j.humpath.2019.04.004 Revencu, N., Boon, L. M., Mendola, A., Cordisco, M. R., Dubois, J., Clapuyt, P., Hammer, F., Amor, D. J., Irvine, A. D., Baselga, E., Dompmartin, A., Syed, S., Martin-Santiago, A., Ades, L., Collins, F., Smith, J., Sandaradura, S., Barrio, V.
R., Burrows, P. E., … Vikkula, M. (2013). RASA1 mutations Dean&Francis and associated phenotypes in 68 families with capillary malformation-arteriovenous malformation. Human Mutation, 34(12), 1632–1641. https://doi.org/10.1002/humu.22431 Ruiz-Llorente, L., Gallardo-Vara, E., Rossi, E., Smadja, D. M.,
Botella, L. M., & Bernabeu, C. (2017). Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia. Expert Opinion on Therapeutic Targets, 21(10), 933–947. https://doi.org/10.1080/14728222.2017.1365839 Shirley, M. D., Tang, H., Gallione, C. J., Baugher, J. D., Frelin, L. P., Cohen, B., North, P. E., Marchuk, D. A., Comi, A. M., & Pevsner, J. (2013). Sturge–Weber Syndrome and Port- Wine Stains Caused by Somatic Mutation in GNAQ. New England Journal of Medicine, 368(21), 1971–1979. https://doi. org/10.1056/NEJMoa1213507 Simonin, F., Karcher, P., Boeuf, J. J.-M., Matifas, A., & Kieffer,
B. L. (2004). Identification of a novel family of G proteincoupled receptor associated sorting proteins. Journal of Neurochemistry, 89(3), 766–775. https://doi.org/10.1111/j.1471- 4159.2004.02411.x Smits, P. J., Konczyk, D. J., Sudduth, C. L., Goss, J. A., &
Greene, A. K. (2020). Endothelial MAP2K1 Mutations in Arteriovenous Malformation Activate the RAS/MAPK Pathway. Biochemical and Biophysical Research Communications, 529(2), 450–454. https://doi.org/10.1016/j.bbrc.2020.06.022
Uller, W., Alomari, A. I., & Richter, G. T. (2014). Arteriovenous malformations. Seminars in Pediatric Surgery, 23(4), 203–207. https://doi.org/10.1053/j.sempedsurg.2014.07.005 Walcott, B. P., Winkler, E. A., Zhou, S., Birk, H., Guo, D., Koch, M. J., Stapleton, C. J., Spiegelman, D., Dionne-Laporte, A., Dion, P. A., Kahle, K. T., Rouleau, G. A., & Lawton, M. T. (2018). Identification of a rare BMP pathway mutation in a nonsyndromic human brain arteriovenous malformation via exome sequencing. Human Genome Variation, 5, 18001. https://doi. org/10.1038/hgv.2018.1 Weinsheimer, S., Brettman, A. D., Pawlikowska, L., Wu, D. C., Mancuso, M. R., Kuhnert, F., Lawton, M. T., Sidney, S., Zaroff, J. G., McCulloch, C. E., Young, W. L., Kuo, C., & Kim,
H. (2012). G Protein-Coupled Receptor 124 (GPR124) Gene Polymorphisms and Risk of Brain Arteriovenous Malformation. Translational Stroke Research, 3(4), 418–427. https://doi. org/10.1007/s12975-012-0202-9 Whistler, J. L., Enquist, J., Marley, A., Fong, J., Gladher,
F., Tsuruda, P., Murray, S. R., & von Zastrow, M. (2002). Modulation of Postendocytic Sorting of G Protein-Coupled Receptors. Science, 297(5581), 615–620. https://doi. org/10.1126/science.1073308
Zhang, M., Liang, L. H., Lu, Y. J., & Cao, X. (2020). G proteincoupled receptor-associated sorting proteins: Function and relevant disorders. Yi Chuan = Hereditas, 42(8), 713–724. https://doi.org/10.16288/j.yczz.20-020 Zhang, T., Liu, G., Zhang, J., Chen, S., Deng, Z., & Xie, M. (n.d.). GPRASP1 is a candidate anti-oncogene and correlates with immune microenvironment and immunotherapeutic efficiency in head and neck cancer. Journal of Oral Pathology & Medicine, n/ a(n/a). https://doi.org/10.1111/jop.13376 Zheng, X., Chang, F., Zhang, X., Rothman, V. L., & Tuszynski, G.
P. (2012). G-protein coupled receptor-associated sorting protein 1 (GASP-1), a ubiquitous tumor marker. Experimental and Molecular Pathology, 93(1), 111–115. https://doi.org/10.1016/ j.yexmp.2012.03.013
Downloads
Published
Issue
Section
License
Copyright (c) 2024 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
